DUBLIN--(BUSINESS WIRE)--The "Systemic Mastocytosis Pipeline Research Monitor, 2020 - Drugs, Companies, Clinical Trials, R&D Pipeline Updates, Status and Outlook" report has been added to ...
There are plenty of blockbuster drugs on the market worldwide to help diabetes patients control their glucose levels. In 2012, Sanofi's (NYSE: SNY) Lantus sat atop the list of best selling diabetes ...
A new study headed by teams at the Wellcome Sanger Institute, EMBL’s European Bioinformatics Institute (EMBL-EBI), and Open Targets has indicated how mutations that cause cancer drug resistance fall ...
Several studies have evaluated patch testing for the diagnosis of drug eruptions, but widespread acceptance of this procedure is lacking in North America. The objective of this review is to address ...
Please provide your email address to receive an email when new articles are posted on . Drugs that treat systemic diseases can be lifesaving, but when these drugs lead to poor ocular health or vision, ...
Every 5 or 10 years, Congress enacts major legislation addressing pressing issues at the Food and Drug Administration (FDA). This year, the biggest reforms since at least 1997 are expected. A decade ...
This systematic literature review reports incidence of adverse drug effects associated with guideline-directed medical therapy for patients with heart failure with reduced ejection fraction.
As costs of cancer care rise, there has been a shift to focus on value. Drug wastage affects costs to patients and health care systems without adding value. Historically, cost-effectiveness analyses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results